Journal ArticleDOI
beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats.
TLDR
The data are consistent with the hypothesis that endorphins act at a presently unknown brain site(s) to increase the central sympathetic outflow to adrenal medulla and peripheral sympathetic nerve endings, thus stimulating peripheral catecholamine release and increasing plasma concentrations of epinephrine, norepinephrine, and dopamine.Abstract:
Intracisternal administration of synthetic human beta-endorphin (0.058-7.25 nmol) in chronically cannulated, conscious, freely moving, adult male rats increased plasma concentrations of epinephrine, norepinephrine, and dopamine in a dose-related manner. Epinephrine secretion was the most sensitive to the stimulatory effect of intracerebral beta-endorphin; plasma epinephrine increased transiently in response to 0.058 nmol. Of the three catecholamines, plasma epinephrine showed the greatest and most rapid response to the largest dose (7.25 nmol) studied. Plasma norepinephrine increased significantly in response to 1.45 nmol, peaking later than plasma epinephrine. Plasma dopamine increased only in response to the highest dose examined. These beta-endorphin effects on plasma catecholamines were inhibited by intraarterial naloxone (1.1 mumol/kg), supporting mediation at opioid receptors. Pretreatment with the ganglionic blocking agent chlorisondamine inhibited the responses of all three catecholamines to intracisternal beta-endorphin. Bilateral adrenal denervation completely prevented the plasma epinephrine response to beta-endorphin and blunted the plasma norepinephrine and dopamine responses. Prior intracisternal administration of hemicholinium-3 blocked the plasma responses of all three catecholamines to intracisternal beta-endorphin, providing evidence for the involvement of central cholinergic neurons in the mechanism mediating beta-endorphin-induced increases in plasma catecholamines. The data are consistent with the hypothesis that endorphins act at a presently unknown brain site(s) to increase the central sympathetic outflow to adrenal medulla and peripheral sympathetic nerve endings, thus stimulating peripheral catecholamine release and increasing plasma concentrations of epinephrine, norepinephrine, and dopamine.read more
Citations
More filters
Journal ArticleDOI
The opiomelanotropinergic neuronal and endocrine systems.
TL;DR: The anatomy, physiology and biochemistry of opiomelanotropinergic neurons are reviewed and the implications of multi-neurotransmitter and multi-hormone neurons and cells are discussed.
Journal ArticleDOI
The neuroanatomy, neurophysiology, and neurochemistry of pain, stress, and analgesia in newborns and children.
TL;DR: The clinical implications of the development of mature anatomic pathways and neurotransmitters in the "pain system" in the human fetus, neonate, and child and the maintenance of cardiovascular stability and hormonal-metabolic homeostasis in newborns and children undergoing surgery or other forms of stress are described.
Journal ArticleDOI
Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism
TL;DR: The suppression of blood lymphocyte proliferation and splenic cytolytic activity of natural killer cells by morphine was opiate receptor-mediated, as indicated by the reversibility by naltrexone of the observed effects of morphine.
Book ChapterDOI
The endocrinology of the opioids.
Mark J. Millan,Albert Herz +1 more
TL;DR: The organization, characteristics, release, and modulation of hypophyseal and other endocrinologically relevant pools of opioid peptides and their possible target sites and functions are discussed.
Journal ArticleDOI
Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA.
TL;DR: Using in situ hybridization, cells containing pro-opiomelanocortin (POMC) mRNA were found in the caudal portion of the NTS and the nucleic acid distribution correlated well with the anatomical distribution of 16k POMC peptide immunoreactivity as determined by immunocytochemistry as discussed by the authors.